ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,1671
0,44%
Bitcoin
68.863,14
1,38%
Brent Oil
81,965
0,81%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Alnylam Pharmaceuticals Inc (ALNY)

  7. Alnylam Pharmaceuticals Inc (ALNY) Notícias

ALNY Alnylam Pharmaceuticals Inc

143,8054
-5,57 (-3,73%)
Após o horário de negociação
Última atualização: 17:48:46
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Alnylam Pharmaceuticals Inc ALNY NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-5,57 -3,73% 143,8054 17:48:46
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
149,50 147,15 149,83 147,76 149,38
mais cotações »

Notícias Recentes

Data Hora Fonte Título
07/05/202409:00BWAlnylam Issues 2023 Corporate Responsibility Report
02/05/202409:00BWAlnylam Pharmaceuticals Reports First Quarter 2024 Financial..
30/04/202408:00PRNUSMedison Pharma and Alnylam Pharmaceuticals Announce..
18/04/202409:00BWAlnylam to Webcast Conference Call Discussing First Quarter..
07/04/202409:00BWAlnylam Presents Positive Results from the KARDIA-2 Phase 2..
20/03/202409:00BWAlnylam to Webcast Investor Event to Discuss Results from..
13/03/202408:30BWAlnylam Launches Hereditary ATTR (hATTR) Amyloidosis..
06/03/202408:50BWAlnylam meldet positive KARDIA-2 Topline-Studienergebnisse,..
05/03/202419:39BWAlnylam annonce des résultats positifs de l’étude KARDIA-2..
05/03/202409:30BWAlnylam Reports Positive KARDIA-2 Topline Study Results..
27/02/202410:30BWAlnylam to Webcast Presentations at Upcoming March Investor..
15/02/202410:00BWAlnylam Pharmaceuticals Reports Fourth Quarter and Full Year..
29/01/202410:00BWAlnylam to Webcast Conference Call Discussing Fourth Quarter..
09/01/202410:05BWAlnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year..
07/01/202420:00BWAlnylam Announces Preliminary* Fourth Quarter and Full Year..
02/01/202409:30BWAlnylam to Webcast Presentation at 42nd Annual J.P. Morgan..
13/12/202309:30BWAlnylam Highlights Significant Progress with Platform..
06/12/202310:00BWAlnylam to Webcast Virtual R&D Day
30/11/202310:00BWAlnylam Ranks #1 on Boston Globe’s Top Places to Work List..
12/11/202314:08BWAlnylam présente des résultats positifs de l'étude KARDIA-1..
11/11/202318:00BWAlnylam Presents Positive Results from the KARDIA-1 Phase 2..
07/11/202310:00BWAlnylam to Webcast Presentations at Upcoming November..
02/11/202309:00BWAlnylam Pharmaceuticals Reports Third Quarter 2023 Financial..
26/10/202315:00BWAlnylam Recognized by Science Magazine as Top Employer for..
25/10/202318:19BWAlnylam Announces Publication of Results from APOLLO-B Phase..
25/10/202312:05BWAlnylam Reports Additional Positive Interim Phase 1 Results..
19/10/202309:00BWAlnylam to Webcast Conference Call Discussing Third Quarter..
10/10/202308:02IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
09/10/202309:23DJNAlnylam Ending Onpattro ATTR-CM Pursuit After FDA Rejection
09/10/202308:30BWAlnylam Announces Receipt of Complete Response Letter from..
06/10/202308:00BWAlnylam to Present Additional Data for Patisiran in Patients..
13/09/202318:48DJNAlnylam Pharmaceuticals Says FDA Panel Votes in Favor of..
13/09/202317:57BWAlnylam Announces Positive Outcome of FDA Advisory Committee..
13/09/202308:00BWAlnylam Stock Trading Halted Today; FDA Advisory Committee..
07/09/202308:00BWAlnylam Reports Positive Topline Results from KARDIA-1 Phase..
06/09/202312:46BWÉlaboration par un groupe international de défenseurs des..
06/09/202311:45BWErstes Empfehlungspaket für die ganzheitliche Betreuung von..
06/09/202304:00BWFirst Set of Recommendations Advocating for the Holistic..
25/08/202318:00BWAlnylam to Appeal Claim Construction Ruling on Two Patents..
03/08/202309:00BWAlnylam Pharmaceuticals Reports Second Quarter 2023..
02/08/202309:30BWAlnylam to Webcast Presentation at Canaccord Genuity 43rd..
24/07/202316:43BWAlnylam gibt Partnerschaft mit Roche zur gemeinsamen..
24/07/202310:11BWAlnylam annonce un partenariat avec Roche pour co-développer..
24/07/202302:00BWAlnylam Announces Partnership with Roche to Co-Develop and..
21/07/202319:21BWアルナイラムによるジレベシランの第1相試験結果がニューイングランド医学誌に掲載
20/07/202309:00BWAlnylam to Webcast Conference Call Discussing Second Quarter..
20/07/202307:42BWAlnylam veröffentlicht Ergebnisse der Phase-1-Studie für..
19/07/202318:00BWAlnylam Announces Publication of Phase 1 Study Results for..
17/07/202303:21BWAlnylam Reports Updated Positive Interim Phase 1 Results for..
30/06/202310:00BWAlnylam Announces Date of Planned FDA Advisory Committee..

Seu Histórico Recente

NASDAQ
ALNY
Alnylam Pharmaceuticals
BOV
EQPA7
EQTL PARA PNC
NYSE
OLN
Olin
NASDAQ
SBNY
Signature Bank
TSXV
AST
Astron Connect
TSXV
JZZ.H
ASX
GLV
Global Oil and Gas
NYSE
ICE
Intercontinental Exchange
TSXV
GBC
NASDAQ
ELTK
Eltek
NASDAQ
LGBT
LGBTQ plus ESG 100
TSXV
NVO
Novo Resources
BOV
SPFG7L
Superfrigo Ind Com PNC
COIN
COMPUSD
Compound
NASDAQ
CTBK
ASX
TLSLOA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados